Vytrus Biotech S.A. Capital Reinvestment Ratio
Vytrus Biotech S.A. capital reinvestment ratio. Vytrus Biotech S.A. (VYT) has a Capital Reinvestment Ratio of 2.19x as of December 2022, meaning it reinvests 2% of its operating cash flow (€225.55K) in capital expenditures (€494.16K). Check VYT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Vytrus Biotech S.A. (2021–2025)
Capital reinvestment ratio of Vytrus Biotech S.A. from 2021 to 2025. This chart tracks Vytrus Biotech S.A.'s Capital Reinvestment Ratio across 5 annual periods. Also explore Vytrus Biotech S.A. annual equity growth to track the company's year-over-year net asset growth rate.
Vytrus Biotech S.A. Capital Reinvestment Ratio by Year (2021–2025)
Vytrus Biotech S.A. capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see Vytrus Biotech S.A. cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | €3.90 Million | €2.68 Million | ▲ +5.2% |
| 2024 | 0.65x | €1.84 Million | €1.20 Million | ▼ -49.4% |
| 2023 | 1.29x | €904.39K | €1.17 Million | ▼ -41.1% |
| 2022 | 2.19x | €225.55K | €494.16K | ▲ +261.0% |
| 2021 | 0.61x | €447.92K | €271.82K | — |